FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
ClearPoint Neuro, Inc. Stock AnalysisComprehensive stock analysis for ClearPoint Neuro, Inc. (CLPT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCLPT
CLPT
ClearPoint Neuro, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CLPT
Home🔹Stocks🔹ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc.

CLPT•NASDAQ

ClearPoint Neuro, Inc.

CLPT•NASDAQ
Market cap
$435.75M
Sentiment

Your view on CLPT

Mkt Cap
$435.75M
Sentiment
Your view
CLPT
ClearPoint Neuro, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CLPT
Company Overview

Overview

What the company does, where it operates, and who runs it.

About ClearPoint Neuro, Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
Joseph Michael Burnett
Headquarters
120 S. Sierra Avenue, Solana Beach, CA, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Joseph Michael Burnett
Headquarters
120 S. Sierra Avenue, Solana Beach, CA, US
Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News